Secretory phospholipases A(2) isolated from Bothrops asper and from Crotalus durissus terrificus snake venoms induce distinct mechanisms for biosynthesis of prostaglandins E-2 and D-2 and expression of cyclooxygenases


Autoria(s): MOREIRA, Vanessa; GUTIERREZ, Jose Maria; SOARES, Andreimar Martins; ZAMUNER, Stella Regina; PURGATTO, Eduardo; TEIXEIRA, Catarina de Fatima Pereira
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2008

Resumo

The effects of myotoxin III (MT-III), a phospholipase A(2) (sPLA(2)) from Bothrops asper snake venom, and crotoxin B (CB), a neurotoxic and myotoxic sPLA2 from the venom of Crotalus durissus terrificus, on cyclooxygenases (COXs) expression and biosynthesis of prostaglandins (PGs) were evaluated, together with the mechanisms involved in these effects. Upon intraperitoneal injection in mice, both sPLA(2)s promoted the synthesis of PGD(2) and PGE(2), with a different time-course. MT-III, but not CB, induced COX-2 expression by peritoneal leukocytes without modification on COX-1 constitutive expression, whereas CB increased the constitutive activity of COX-1. MT-III increased the enzymatic activity of COX-1 and COX-2. Similar effects were observed when these sPLA(2)s were incubated with isolated macrophages, evidencing a direct effect on these inflammatory cells. Moreover, both toxins elicited the release of arachidonic acid from macrophages in vitro. inhibition of cPLA(2) by AACOCF(3), but not of iPLA(2) by PACOCF(3) or BEL, significantly reduced PGD2, PGE2 and arachidonic acid (AA) release promoted by MT-III. These inhibitors did not affect MT-III-induced COX-2 expression. In contrast, cPLA2 inhibition did not modify the effects of CB, whereas iPLA2 inhibition reduced PGD2 and AA production induced by CB. These findings imply that distinct regulatory mechanisms leading to PGs` synthesis are triggered by these snake venom sPLA(2)s. Such differences are likely to explain the dissimilar patterns of inflammatory reaction elicited by these sPLA(2)s in vivo. (C) 2008 Elsevier Ltd. All rights reserved.

Fundacao de Amparo A Pesquisa do Estado de Sao Paulo (FAPESP), Brazil[02/13863-2]

Fundacao de Amparo A Pesquisa do Estado de Sao Paulo (FAPESP), Brazil[07/03336-9]

Fundacao de Amparo A Pesquisa do Estado de Sao Paulo (FAPESP), Brazil[02/13458-0]

Conselho Nacional de Pesquisa (CNPq), Brazil[301199/91-4]

Identificador

TOXICON, v.52, n.3, p.428-439, 2008

0041-0101

http://producao.usp.br/handle/BDPI/19520

10.1016/j.toxicon.2008.06.012

http://dx.doi.org/10.1016/j.toxicon.2008.06.012

Idioma(s)

eng

Publicador

PERGAMON-ELSEVIER SCIENCE LTD

Relação

Toxicon

Direitos

restrictedAccess

Copyright PERGAMON-ELSEVIER SCIENCE LTD

Palavras-Chave #Venom phospholipase A(2) #Crotoxin B #Arachidonic acid #Prostaglandins #Cyclooxygenases #cPLA(2) #iPLA(2) #Macrophages #NF-KAPPA-B #GROUP-II PHOSPHOLIPASE-A(2) #MAST-CELLS #MYOTOXIN-II #CROTOXIN-B #BIOLOGICAL-ACTIVITIES #CATALYTIC-ACTIVITY #FATTY-ACIDS #MACROPHAGES #ACTIVATION #Pharmacology & Pharmacy #Toxicology
Tipo

article

original article

publishedVersion